ClinicalTrials.govpublic full text
Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis
kidney disease, chronic kidney disease (ckd), haemoglobin (hb), erthropoetin (epo), end stage renal disease (esrd), recombinant human erthropoetic (rhuepo), anaemia, darbepoetin alfa, aranesp®, haemodialysis, clinical trial, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 835022
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.